I graduated from Ehime University, Japan, obtaining a Doctor of Medicine degree and a medical license in 2004. I had been training and working as a general surgeon, breast surgeon, and oncologist in clinical hospital, cancer center, and Hiroshima University Hospital. I received my PhD degree for research on Wnt5a signaling pathway in breast cancer from Hiroshima University, Japan, in 2018. My long-term research goal is to elucidate the mechanism of late recurrence in especially ER-positive breast cancer and establish personalized therapy for recurrent breast cancer. Since I became a medical doctor, I had seen huge breast cancer patients with various disease conditions in clinic. I had frequently seen the patients with recurrence, most of which eventually die because of the disease. I had been feeling terribly sad and really eager to develop novel therapeutic strategy to overcome recurrent breast cancer. When I was a PhD student, I thought that particular signaling pathways may link to the drug sensitivity and prognosis of breast cancer, and if we identify such pathways, they may serve as drug targets as well as predictive biomarkers. I hope that I would like to make contributions to clinical applications and become a bridge between basic researchers and clinicians. I currently work for Department of Breast Oncology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center since April 2022 as a breast surgeon and oncologist.
Kure Medical Center
Kure, Hiroshima, Japan
Department of Breast Surgery and Oncology
2015 Grant-in-Aid
Hiroshima University, Japan
Title: A study on the possibility of novel molecular target therapy using anti-Wnt5a antibody against Wnt5a-positive breast cancer Role: PhD student researcher
2021 Grant-in-Aid
Hiroshima University, Japan
Title: The mechanism of resistance to CDK4/6 inhibitor in breast cancer Role: PI
2022 Grant-in-Aid Young Scientists B (Grant number: 22K16444)
The Ministry of Education, Culture, Sports, Science and Technology, Japan
Title: Implementation of personalized breast cancer medicine based on elucidation of CDK4/6 inhibitor resistance mechanism using single cells Role: PI
Breast Oncology Staff: Surgeon, Oncologist, and Physician Researcher
Department of Breast Oncology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Japan
01 Apr 2022 - present
Breast Surgical Staff: Surgeon, Oncologist, and Physician Researcher
Department of Breast Surgery, Hiroshima University Hospital, Japan Department of Surgical Oncology, Research Center for Radiation Casualty Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University, Japan
01 Apr 2021 - 01 Mar 2022
Post Doctoral Researcher
Cancer Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation, Doha, Qatar
01 Apr 2019 - 01 Dec 2020
Breast Surgical Staff: Surgeon and Oncologist
Department of Surgery, Saiseikai Hiroshima Hospital, Japan
01 Apr 2016 - 01 Mar 2019
Breast Surgical Staff: Clinician
Department of Breast Surgery, Oikawa Hospital, Japan
01 Apr 2012 - 01 Mar 2015
Surgical Staff
Department of Surgery, Hiroshima University Hospital, Japan
01 Apr 2011 - 01 Mar 2012
Senior Resident
Department of Surgery, Shikoku Cancer Center, Japan
01 Apr 2009 - 01 Mar 2011
Senior Resident
Department of Surgery, Hiroshima City Asa Citizens Hospital, Japan
01 Apr 2006 - 01 Mar 2009
Junior Resident
Hiroshima City Asa Citizens Hospital, Japan
01 Apr 2004 - 01 Mar 2006